Dr. Sarkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
NYU Langone Health - Tisch Hospital
550 1st Ave
New York, NY 10016Phone+1 212-263-1530
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2015 - 2016
- Icahn School of Medicine at Mount Sinai (Mount Sinai Hospital)Residency, Pathology-Anatomic and Clinical, 2012 - 2016
- Maharani Laxmi Bai Medical CollegeClass of 1992
Certifications & Licensure
- NY State Medical License 2015 - 2026
- KY State Medical License 2015 - 2018
- American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- 691 citationsThe cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetesJanet M. Wenzlau, Kirstine Juhl, Liping Yu, Ong Moua, Suparna A. Sarkar
Proceedings of the National Academy of Sciences of the United States of America. 2007-10-23 - 67 citationsCholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.Saamia Faruqui, Fidelis C. Okoli, Sonja Olsen, David M. Feldman, Harmit Kalia
The American Journal of Gastroenterology. 2021-07-01 - 106 citationsExpression and Regulation of Chemokines in Murine and Human Type 1 DiabetesSuparna A. Sarkar, Catherine E. Lee, Francisco Victorino, Tom T. Nguyen, Jay A. Walters
Diabetes. 2012-02-01
Grant Support
- Indoleamine 2, 3 Dioxygenase Signaling And Function In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009
- Indoleamine 2, 3 Dioxygenasesignaling And Function In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: